Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2019–2023 · award
Yoga Program for Couples Coping with Lung Cancer
Kathrin Milbury · The University of Texas MD Anderson Cancer Center
2019–2024 · award
Mechanisms of isocitrate dehydrogenase variants in cancer
2019 · award
Neurocognitive Sequelae of Radiation Therapy for Head and Neck Cancer
Andrew Mcdonald · University of Alabama at Birmingham
2019 · award
Delineating a Pathway of Colorectal Cancer Downstream of Let-7 microRNAs
Blair Madison · Washington University in St. Louis
2019–2022 · award
Role of ARID1A in ovarian carcinogenesis
2019 · award
Targeting the nuclear export factor NXT1 in neuroblastoma
Clare Malone · Dana-Farber Cancer Institute
2019–2020 · award
Image-based Biomarker to Differentiate Tumor Progression from Tumor Necrosis and Pseudoprogression after Radiation Therapy for Lung Cancer
2019 · award
Define predictive biomarkers for ATR inhibitors
Chao Wang · The University of Texas MD Anderson Cancer Center
2019–2022 · award
Precise and Long-term Immunotherapy for Potent Treatment of Melanoma
Eric Appel · The Board Of Trustees Of The Leland Stanford Junior University
2019 · award
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in PDAC
Jason Kwon · Dana-Farber Cancer Institute
2019–2023 · award
Novel Treatment of Melanoma Through Sensory Nerve Targeting
2019–2024 · award
Investigate the role of USP15 in breast cancer radiochemotherapy
Huadong Pei · George Washington University
2019–2022 · award
Elucidating the role AMPK plays in Human Cytomegalovirus infection
2019–2021 · award
Quantification of translational control by transcript leader elements
Rachel Niederer · Yale University
2019–2022 · award
Identifying Metabolic Dependencies in the Pancreatic Tumor Microenvironment
2019–2021 · award
Examining the Role of RNF168 in BRCA1 Mutant Breast Cancer
John Krais · Washington University in St. Louis
2019–2024 · award
Intravesical cisplatin chemotherapy and mechanisms of resistance for NMIBC
2019–2023 · award
Diagnostic tools for monitoring immune responses to cancer immunotherapy
Jennifer Murphy · The Regents Of The University Of California, Los Angeles
2019–2020 · award
Functional Genomic Interrogation of SETD2
2019–2022 · award
Role and Regulation of RNA Localization in Cellular Migration and Invasion
Megan Norris · University of California, Riverside
2019–2025 · award
Choose2Quit - Improving Equity in Smoking Cessation for Low-income Adults
2019–2024 · award
Institutional Research Grant
2019–2021 · award
Exploring the cancer mutational landscape of G proteins with new biosensors
Marcin Maziarz · Trustees Of Boston University
2019–2024 · award
Role of aberrant enhancer activation in colorectal cancer
Kunal Rai · The University of Texas MD Anderson Cancer Center
2019–2023 · award
The regulation of cell cycle by long non-coding RNA in breast cancer
2019–2024 · award
Ibrutinib as immunomodulatory reagent to enhance anti-tumor T cell response
2019–2024 · award
Role of mitochondrial creatine kinase 1 in breast and ovarian cancers
2019–2022 · award
Targeting menin as a treatment in high HOXA acute leukemias
Jolanta Grembecka · Regent University
2019–2022 · award
Investigating RHAMM Contributions to Breast Cancer Progression
2019 · award
Microenvironmental Sensing and Imaging of Tumor Metastasis
Liangliang Hao · Massachusetts Institute of Technology
2019–2023 · award
Targeting transcription factors in triple negative basal breast cancer
2019–2020 · award
APE1 cleansing of oxidatively damaged DNA ends
2019–2024 · award
Role of UHRF1 in osteosarcoma
2019–2024 · award
Therapeutic targeting of oncogenic SMARCB1 mutants
2019–2023 · award
Transit-amplifying cells and chemotherapy-induced toxicity
Ya-Chieh Hsu · President & Fellows Of Harvard College
2019–2023 · award
Ubiquitin ligases in breast cancer proliferation and therapeutic resistance
Michael Emanuele · University of North Carolina at Chapel Hill
2019 · award
Targeting de novo nucleotide synthesis to overcome radioresistance in GBM
2019–2024 · award
Analyzing Outcomes for African American Breast Cancer Patients & Caregivers
2019–2021 · award
Chemical proteomic strategy to identify druggable vulnerabilities in cancer
2019–2020 · award
Oligomerization of Chemokine Receptor CXCR4 Mediates Tolerance
Hazem Abdelkarim · University of Chicago
